Evidence map›Paper›PMID 32825849›Full record

ArticleMicrobiome2020

Antimicrobial drug use in the first decade of life influences saliva microbiota diversity and composition.

Sajan C Raju, Heli Viljakainen, Rejane A O Figueiredo, Pertti J Neuvonen, Johan G Eriksson, Elisabete Weiderpass, Trine B Rounge

Open access · goldAbstract readVideo-Audio Media
In one paragraph

Article in Microbiome, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 37 citations in OpenAlex.

  1. Trial
  2. Gut Microbial Topology and Metabolic Signatures Associated With Colorectal Neoplasia.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Enterobacteriaceae as a Key Indicator of Huanglongbing Infection inInternational journal of molecular sciences · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Association of exogenous factors with molecular epidemiology ofSaudi journal of biological sciences · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 4 countries.

Sajan C RajuFolkhälsan Research Center, Topeliuksenkatu 20, 00250, Helsinki, Finland.
Heli ViljakainenFolkhälsan Research Center, Topeliuksenkatu 20, 00250, Helsinki, Finland.
Rejane A O FigueiredoFolkhälsan Research Center, Topeliuksenkatu 20, 00250, Helsinki, Finland.
Pertti J NeuvonenDepartment of Clinical Pharmacology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Johan G ErikssonFolkhälsan Research Center, Topeliuksenkatu 20, 00250, Helsinki, Finland.
Elisabete WeiderpassInternational Agency for Research on Cancer, World Health Organization, Lyon, France.
Trine B RoungeFolkhälsan Research Center, Topeliuksenkatu 20, 00250, Helsinki, Finland. trine.rounge@kreftregisteret.no.ORCID 0000-0003-2677-2722
University of Helsinki · FICentre international de recherche sur le cancer · FR

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundThe human microbiota contributes to health and well-being. Antimicrobials (AM) have an immediate effect on microbial diversity and composition in the gut, but next to nothing is known about their long-term contribution to saliva microbiota. Our objectives were to investigate the long-term impact of AM use on saliva microbiota diversity and composition in preadolescents. We compared the lifetime effects by gender and AMs. We used data from 808 randomly selected children in the Finnish Health In Teens (Fin-HIT) cohort with register-based data on AM purchases from the Social Insurance Institution of Finland. Saliva microbiota was assessed with 16S rRNA (V3-V4) sequencing. The sequences were aligned to the SILVA ribosomal RNA database and classified and counted using the mothur pipeline. Associations between AM use and alpha-diversity (Shannon index) were identified with linear regression, while associations between beta-diversity (Bray-Curtis dissimilarity) and low, medium or high AM use were identified with PERMANOVA.

resultsOf the children, 53.6% were girls and their mean age was 11.7 (0.4) years. On average, the children had 7.4 (ranging from 0 to 41) AM prescriptions during their lifespan. The four most commonly used AMs were amoxicillin (n = 2622, 43.7%), azithromycin (n = 1495, 24.9%), amoxicillin-clavulanate (n = 1123, 18.7%) and phenoxymethylpenicillin (n = 408, 6.8%). A linear inverse association was observed between the use of azithromycin and Shannon index (b - 0.015, p value = 0.002) in all children, the effect was driven by girls (b - 0.032, p value = 0.001), while not present in boys. Dissimilarities were marked between high, medium and low users of all AMs combined, in azithromycin users specifically, and in boys with amoxicillin use. Amoxicillin and amoxicillin-clavulanate use was associated with the largest decrease in abundance of Rikenellaceae. AM use in general and phenoxymethylpenicillin specifically were associated with a decrease of Paludibacter and pathways related to amino acid degradations differed in proportion between high and low AM users.

conclusionsA systematic approach utilising reliable registry data on lifetime use of AMs demonstrated long-term effects on saliva microbiota diversity and composition. These effects are gender- and AM-dependent. We found that frequent lifelong use of AMs shifts bacterial profiles years later, which might have unforeseen health impacts in the future. Our findings emphasise a concern for high azithromycin use, which substantially decreases bacterial diversity and affects composition as well. Further studies are needed to determine the clinical implications of our findings. Video Abstract.

Indexed as

AdolescentAnti-Bacterial AgentsChildFemaleFinlandHumansMaleMicrobiotaProspective StudiesRNA, Ribosomal, 16SSalivaTime FactorsAnti-Bacterial AgentsRNA, Ribosomal, 16SAntibioticsAzithromycinGender differenceLifelong antimicrobial useSaliva microbiota

Identifiers

PMID32825849
PMCPMC7441731
OpenAlexW3080241174

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.